Carl Anthony Evans

Director, CNS Pharmaceuticals, Inc.

Companies

CNS Pharmaceuticals, Inc.Board member Nov 8, 2019 to Apr 10, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

CNS Pharmaceuticals, Inc. CNSP33,458 shares²$162.3K at $4.85Feb 1, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 1, 2024Bought 33,333 shares at $0.30 of CNS Pharmaceuticals, Inc.²
Mar 8, 2022Granted 3,750 shares at $0.27 of CNS Pharmaceuticals, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCNS Pharmaceuticals, Inc., Board member
2
SEC EDGARCNS Pharmaceuticals, Inc. shares after the filing of Feb 1, 2024
3
SEC EDGARForm 4 filed Mar 9, 2022